Keywords: سرطان‌های سر و گردن; Acupuncture; Head and neck cancer; Radiation therapy; Xerostomia
مقالات ISI سرطان‌های سر و گردن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان‌های سر و گردن; Complementary and Alternative Medicine; Head and neck cancer; Natural compounds; Ethics
Keywords: سرطان‌های سر و گردن; Radiation; Chemoradiation; Head and neck cancer; Proton therapy; HPV; TORS; IMRT; IMPT;
Keywords: سرطان‌های سر و گردن; Oral cavity cancer; Oral cancer; Squamous cell carcinoma; Head and neck cancer;
Alterations found in the mouth of patients treated with head and neck radiotherapy. Medellin, Colombia
Keywords: سرطان‌های سر و گردن; Head and neck cancer; mucositis; dysgeusia; trismus; xerostomia; radiotherapy oral sequels; oral candidiasis; Cáncer de cabeza y cuello; mucositis; disgeusia; trismus; xerostomÃa; secuelas orales de radioterapia; candidiasis oral;
Patients with integrated HPV16 in head and neck cancer show poor survival
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Human papillomavirus; Survival; Incidence; Age; Year of birth;
The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England
Keywords: سرطان‌های سر و گردن; Clinical trial; Patient recruitment; High-volume hospitals; Low-volume hospitals; Outcomes research; Survival analysis; Head and neck cancer;
Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck
Keywords: سرطان‌های سر و گردن; Re-irradiation; Head and neck cancer; HPV; Recurrent; Prognosis;
Frequent methylation of DAB2, a Wnt pathway antagonist, in oral and oropharyngeal squamous cell carcinomas
Keywords: سرطان‌های سر و گردن; HNSCC; head and neck squamous cell carcinoma; OSCC; oral squamous cell carcinoma; Oral cancer; Head and neck cancer; DAB2; DNA methylation; Wnt pathway;
New evidence-based guideline for HPV testing in head and neck cancers
Keywords: سرطان‌های سر و گردن; HPV testing; Head and neck cancer; Guideline; Evidence-based guideline; College of American Pathologists; Oropharyngeal squamous cell carcinoma;
Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Guidelines; Contouring; Margin expansion; Microscopic tumour;
Review of HaNDLE-on-QoL: a database of published papers that use questionnaires to report quality of life in patients with cancer of the head and neck
Keywords: سرطان‌های سر و گردن; Head and Neck Cancer; Quality of life; questionnaires; Patient Reported Outcomes; Review;
Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease
Keywords: سرطان‌های سر و گردن; ICT; induction chemotherapy; CCRT; concurrent chemoradiation; OPSCC; oropharyngeal squamous cell carcinoma; HR; hazard ratio; Oropharyngeal cancer; Squamous cell carcinoma; P16-positive; HPV-associated; Low-neck disease; N3 lymphadenopathy; Distant metast
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)
Keywords: سرطان‌های سر و گردن; Radiotherapy; Head and neck cancer; Cetuximab; Durvalumab; Immunotherapy;
Comparison of single and dual energy CT for stopping power determination in proton therapy of head and neck cancer
Keywords: سرطان‌های سر و گردن; Proton therapy; Stopping power ratio; Dual-energy CT; Water-equivalent path length; Head and neck cancer;
HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynx
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Human papillomavirus; Predictive biomarker; Metastatic squamous cell cancer; Systemic therapy;
A case-control study of non-AIDS-defining cancers in a prospective cohort of HIV-infected patients
Keywords: سرطان‌های سر و گردن; HIV infection; Non-AIDS defining cancers; Non AIDS-defining illnesses; Hepatocellular carcinoma; Lung cancer; Anal cancer; Head and neck cancer; Skin cancer; Hodgkin's lymphoma; Antiretroviral therapy; Infección por VIH; Tumores no definitorios de sida;
Estudio caso-control de tumores no definitorios de sida en una cohorte prospectiva de pacientes infectados por el VIH
Keywords: سرطان‌های سر و گردن; Infección por VIH; Tumores no definitorios de sida; Enfermedades no definitorias de sida; Hepatocarcinoma; Cáncer de pulmón; Cáncer anal; Cáncer de cabeza y cuello; Cáncer de piel; Linfoma de Hodgkin; Tratamiento antirretroviral; HIV infection; Non-
TRACHY score: a simple and effective guide to management of the airway in head and neck cancer
Keywords: سرطان‌های سر و گردن; tracheostomy; head and neck cancer; airway management; scoring; risk factors;
HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancers
Keywords: سرطان‌های سر و گردن; Human immunodeficiency virus; Human Papillomavirus; Head and neck cancer; PD-1; PD-L1; Immune checkpoint blockade; Antigen processing machinery;
Postoperative staging of the neck dissection using extracapsular spread and lymph node ratio as prognostic factors in HPV-negative head and neck squamous cell carcinoma patients
Keywords: سرطان‌های سر و گردن; Extracapsular spread; Lymph node ratio; pN; TNM classification; Head and neck cancer; HPV-negative;
Effect of adjuvant radiotherapy treatment center volume on overall survival
Keywords: سرطان‌های سر و گردن; AJCC; American Joint Committee on Cancer; CI; confidence interval; HHAC; historically high accrual centers; HLAC; historically low-accrual centers; HR; hazard ratio; HVC; high volume center; IMRT; intensity-modulated radiation therapy; LVC; low volume cen
Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: A French GETTEC group study
Keywords: سرطان‌های سر و گردن; Transoral robotic surgery; Pyriform sinus cancer; Robotic hypopharyngectomy; Hypopharyngeal squamous cell carcinoma; Head and neck cancer; Organ preservation;
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma
Keywords: سرطان‌های سر و گردن; Cisplatin; Cetuximab; Oropharyngeal neoplasms; Chemoradiotherapy; Head and neck cancer; Human papillomavirus; P16 protein; Oropharyngeal cancer; Dose fractionation; Radiotherapy; CRT; chemoradiation; DMFS; distant-metastasis-free survival; IR-RPA; interme
Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma
Keywords: سرطان‌های سر و گردن; HPV; Oropharyngeal; Adjuvant radiotherapy; Minimally invasive; Head and neck cancer;
AJCC-8ed nodal staging does not predict outcomes in surgically managed HPV-associated oropharyngeal cancer
Keywords: سرطان‌های سر و گردن; Head and neck cancer; TORS; HPV; Staging; Oropharyngeal cancer; Neck dissection; Robotic; Transoral;
AJCC 8th Edition oral cavity squamous cell carcinoma staging - Is it an improvement on the AJCC 7th Edition?
Keywords: سرطان‌های سر و گردن; Oral cancer; Squamous cell carcinoma; Prognosis; Head and neck cancer; TNM staging; AJCC;
Detection of high PD-L1 expression in oral cancers by a novel monoclonal antibody L1Mab-4
Keywords: سرطان‌های سر و گردن; PD-L1; Programmed cell death-ligand 1; PD-1; programmed cell death-1; CBIS; cell-based immunization and screening; SCC; squamous cell carcinoma; ACC; adenoid cystic carcinoma; MEC; mucoepidermoid carcinoma; CTLA-4; cytotoxic T-lymphocyte-associated antige
Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Locally advanced; Induction; Neo-adjuvant; Nab-paclitaxel;
Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer
Keywords: سرطان‌های سر و گردن; MAGE-A11; Melanoma-associated antigens; Head and neck cancer; Erlotinib; Afatinib;
Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Nasopharyngeal carcinoma; Intensity modulated radiation therapy; Radiation-induced toxicity; Oral mucositis; Predictive model;
Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab
Keywords: سرطان‌های سر و گردن; Exosome; Extracellular vesicle; Epithelial-mesenchymal transition; Epidermal growth factor receptor; Oral cancer; Head and neck cancer;
The Danish Head and Neck Cancer fast-track program: a tertiary cancer centre experience
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Fast-track program; Multidisciplinary; Denmark;
Emerging microRNAs in cancer diagnosis, progression, and immune surveillance
Keywords: سرطان‌های سر و گردن; Cancer immunity; miR-21; miR-375; oncomiR; Prognostic biomarker; RAS pathway; AKT; serine/threonine-protein kinase; CIP2A; cancerous inhibitor of PP2A; ERK; extracellular-signal-regulated kinase; FFPE; formalin-fixed, paraffin-embedded; HNC; head and neck
Is accurate contouring of salivary and swallowing structures necessary to spare them in head and neck VMAT plans?
Keywords: سرطان‌های سر و گردن; Contouring; Head and neck cancer; Knowledge-based planning;
Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features
Keywords: سرطان‌های سر و گردن; FMISO; FDG; Hypoxia; Radiomics; PET; Head and neck cancer;
18F-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia
Keywords: سرطان‌های سر و گردن; Xerostomia; NTCP; Image biomarkers; Head and neck cancer; FDG-PET; Radiomics;
Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Fatigue; Radiation therapy; Quality of life; Brain dose;
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy
Keywords: سرطان‌های سر و گردن; SDF-1; CXCR4; Head and neck cancer; Prognostic; Biomarker; Primary radiochemotherapy;
Vanderbilt head and neck symptom survey, version 2.0: Clinical and research utility for identification of symptom clusters and changes in symptoms over time
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Longitudinal symptom assessment; Symptom cluster; Self-report tool; Quality of life;
Benzethonium chloride activates ER stress and reduces proliferation in HNSCC
Keywords: سرطان‌های سر و گردن; HNSCC; Head and neck cancer; High throughput screen; HTS; CHOP; Benzethonium chloride; Moxidectin; Unfolded protein response; ER stress; OSCC; Oral cancer;
Nanomedicine, an emerging therapeutic strategy for oral cancer therapy
Keywords: سرطان‌های سر و گردن; Nanomedicine; Oral cancer therapy; Head and neck cancer; Nanoparticle-based drug delivery; Liposomes; NP; nanoparticle; EPR; enhanced permeability and retention; PLGA; poly(lactic-co-glycolic acid); PEG; polyethylene glycol; PEI; polyethylenimine; CS; chi
Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Salvage; Recurrence; Laryngectomy; Tumor infiltrating lymphocytes; CD4; CD8; Survival; Prognosis;
Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Neoplasm staging; Kaplan-Meier estimate; TNM stage; Human papillomavirus; Oropharyngeal cancer; Squamous cell carcinoma; Survival analysis; AJCC; American Joint Commission on Cancer; OPSCC; Oropharyngeal Squamous Cell Cancer; HPV; Hu
Venous thromboembolism incidence in head and neck surgery patients: Analysis of the Veterans Affairs Surgical Quality Improvement Program (VASQIP) database
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Venous thromboembolism; Deep vein thrombosis; Pulmonary embolus; Morbidity; Mortality;
The impact of HPV status on weight loss and feeding tube use in oropharyngeal carcinoma
Keywords: سرطان‌های سر و گردن; Human papillomavirus; HPV; Oropharynx cancer; Weight loss; Radiotherapy; Head and neck cancer; Prophylactic feeding tubes; Reactive feeding tubes; Chemotherapy; Nutrition;
Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset
Keywords: سرطان‌های سر و گردن; Metformin; Diabetes; Head and neck cancer; Warburg effect;
DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Systemic inflammation; DNA methylation; Neutrophil-to-lymphocyte ratio; Lymphocyte-to-monocyte ratio; Overall survival; mdNLR; mdNLR; Methylation derived Neutrophil-to-Lymphocyte Ratio; mdLMR; Methylation derived Lymphocyte-to-Monocy
The transcriptional co-activator YAP: A new player in head and neck cancer
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Hippo pathway; YAP; TAZ; Cell growth; Cell proliferation; YAP inhibitors;
HEY1 is expressed independent of NOTCH1 and is associated with poor prognosis in head and neck squamous cell carcinoma
Keywords: سرطان‌های سر و گردن; Head and neck cancer; Head and neck squamous cell carcinoma; Notch signaling; JAG1; HEY1; Survival;